Adam J. Gordon, MD MPH FACP FASAM
Editor-in-Chief, Substance Use & Addiction
383 Colorow Building, Room 203 E
Salt Lake City, UT 84108
(Note: DO NOT mail manuscripts.)
Connect with Substance Use & Addiction Journal
Twitter: @SAj_AMERSA (https://twitter.com/SAj_AMERSA)
Adam J. Gordon, MD, MPH, FACP, DFASAM has a professional mission to improve the access and quality of care of patients who have vulnerabilities, including those with addiction and substance use disorders. He is the Elbert F. and Marie Christensen Endowed Research Professor, tenured Professor of Medicine and Psychiatry and Associate Chief of Epidemiology, at the University of Utah School of Medicine and the Section Chief of Addiction Medicine at the VA Salt Lake City Health Care System. He is a board-certified internal medicine and addiction medicine physician and is a Fellow in the American College of Physicians (FACP) and a Distinguished Fellow in the American Society of Addiction Medicine (DFASAM). He is the PI of the Greater Intermountain Node (GIN), a Center site of the NIH NIDA Clinical Trials Network; he founded and is the Director of the Program for Addiction Research, Clinical Care, Knowledge, and Advocacy (PARCKA); and he founded and is the Emeritus Director the Vulnerable Veteran Innovative Patient-Aligned-Care-Team (VIP) Initiative, a clinical-evaluation initiative at the VA Salt Lake City Health Care System. He is a Core Faculty member of the VA Salt Lake City Informatics, Decision-Enhancement and Analytic Sciences (IDEAS) Center, a Department of Veterans Affairs Health Services Research and Development (HSR&D) Center of Innovation (COIN).
He has a 25-year track record of conducting research on the quality, equity, and efficiency of health care for vulnerable populations, including those who are homeless and those with substance use disorders. A major theme of his research includes examining the efficacy, effectiveness, and implementation of evidence-based identification, assessment, and treatments for patients with addiction. His methodologic skills include health services, clinical trial, large database, and implementation science research. He has received efforts on over 100 federal peer reviewed grants from the NIH, VA, AHRQ, PCORI, and SAMHSA. He has authored over 315 peer reviewed articles (15.3% first authored, 27.2% senior authored, 40.8% authored with mentee) in high impact journals (e.g., JAMA, BMJ, Lancet; H-index=56) and presented/published hundreds of scholarly works. As evidence of how his research has impacted clinical care and his profession, he was awarded one of VA HSR&D’s highest honors by receipt of the 2021 VA Health Services Research and Development (HSR&D) “Health System Impact Award” and received the 2022 David C. Lewis, MD Service to Association for Multidisciplinary Education and Research in Substance Use and Addiction (AMERSA) Award.
He has mentored undergraduate, graduate, MD, and PhD trainees, VA and K- Career Development Awardees, and junior through tenured faculty. In addition, his post-doctoral mentees have received research Career Development Awards and have obtained large research awards. He is a primary or secondary mentor on over a dozen current or prior VA, NIH K-, or institutional K-awards. He has been honored locally and nationally for my mentorship abilities: he was named as an inaugural VA Health Services Research and Development National Mentor Network (MNet) mentor, received the “Allen Humphrey Excellence in Medical Student Research Mentoring Award” from the University of Pittsburgh School of Medicine, and was the recipient of the 2013 W. Anderson Spickard, Jr. Excellence in Mentorship Award from Association for Multidisciplinary Education and Research in Substance Use and Addiction (AMERSA).
He lives in Salt Lake City, Utah with his wife, Molly Conroy; three children Lillian, Neil, and Martha; “King” Arthur (a cat); Tristan the wonder dog; and a bunch of pond fish. In his spare time, he enjoys gardening, particularly deep shade perennial plants.
In a 20+ year track record of leading research on the quality, equity, and efficiency of health care for vulnerable populations, he has led national VA Initiatives and research programs to improve the care of patients with addiction; received efforts on grants from VA HSR&D/QUERI, the NIH, AHRQ, PCORI, SAMHSA, and Foundations; authored over 225 peer reviewed scientific manuscripts; and is the Editor-in-Chief of the journal Substance Abuse. He is passionate about interdisciplinary, multidisciplinary, and transdisciplinary clinical care and scholarship. He lives in Salt Lake City with his wife and three children.
Colleen Corte, PhD, RN, FAAN is Associate Professor Emerita at the University of Illinois at Chicago College of Nursing where she taught Research Design and Methods for PhD students and served as Director of the PhD program. Dr. Corte’s program of research is focused on the ‘drinker identity’ as a cognitive vulnerability for alcohol use and alcohol problems. She found evidence of this emerging identity – a powerful predictor of alcohol use – in children as young as 9-12 years of age. She has focused on identifying modifiable precursors of the drinker identity in a variety of samples including children, adolescents, young adults, and sexual minority (LGBT) young people.
Dr. Corte has published widely in interdisciplinary substance use journals as well as nursing research and clinical journals, with many papers co-authored by PhD students. Her research has been recognized by the Research Society on Alcoholism and the Midwest Nursing Research Society. In 2021, she received the Betty Ford Award from AMERSA. Dr. Corte is also a Fellow in the American Academy of Nursing.On a personal note, she and her husband have been boaters for many years. After retiring, they sold their “dirt” home and have lived full-time aboard their 42 foot Trawler, Lady Kadey. In 2022, she and her husband completed the Great Loop, a 5500+ mile system of waterways that encompass the eastern portion of the United States. It is made up of both natural and man-made waterways, with the route including the Atlantic Intracoastal Waterway, the New York State Canals, the Great Lakes, the inland rivers and the Gulf of Mexico.
Babalola Faseru, MD, MPH is a Tenured Professor with joint appointments in the Department of Population Health and the Department of Family Medicine at the University of Kansas Medical Center (KUMC). He is also the Consultant Medical Epidemiologist at the Bureau of Health Promotion, Kansas Department of Health and Environment (KDHE). He is the Director of the Tobacco Treatment Education Program at the University of Kansas. He is a Councilor and Chair of the Diversity, Inclusion and Equity Committee of the Council for Tobacco Treatment Training Programs (CTTTP), and a member of the National Certification Commission for Addiction Professionals Nicotine Dependence Specialist Task Force. He Chairs the Education subcommittee of the International Association for the Study of Lung Cancer (IASLC) Tobacco Control and Smoking Cessation Committee. He has served as the Lead Section Editor of the Epidemiology and Prevention Section of the Seventh Edition of the ASAM Principles of Addiction Medicine and on the Executive Board of the Association for Multidisciplinary Education and Research in Substance use and Addiction (AMERSA) as Member-at-Large (2011-2013), Treasurer (2013-2015) and as Associate Editor of Substance Abuse Journal (SAj) from 2013-2022.
Dr. Faseru has 17 years of clinical trial research experience with a focus on reducing tobacco-related health disparities affecting diverse populations including African Americans, American Indians, and hospitalized patients. He has published over 90 peer reviewed articles in high impact journals (h-index 23; i10-index 48) including JAMA, Journal of National Cancer Institute, Cochrane Database of Systematic Review, Clinical Pharmacology and Therapeutics, Addiction, American Heart Journal, and Cancer Epidemiology Biomarkers and Prevention.
He obtained his medical degree from Obafemi Awolowo University, Ile-Ife, Nigeria; Master of Public Health from the University of Kuopio (now University of Eastern Finland) in Finland with post-doctoral cancer research fellowship from the WHO International Agency for Research on Cancer (IARC) Lyon, France. He also completed Postdoctoral research fellowship in smoking cessation and nicotine dependence and NIH K30 Fellowship in clinical epidemiology at the University of Kansas Medical Center before his faculty appointment. Dr. Faseru received the Excellence award in Public Health Teaching at the University of Kansas School of Medicine in 2011, 2014 and 2022.
He lives in Olathe, Kansas with his wife Bukky and three children, Tomiwa, Kunmi and Kunle. He enjoys playing the piano and the organ.
Ingrid A. Binswanger, MD, MPH, MS is a Senior Clinician Investigator at the Institute for Health Research at Kaiser Permanente Colorado and practices Addiction Medicine with the Colorado Permanente Medical Group. She is also Director of Substance Use and Harm Reduction Research Development in the Division of General Internal Medicine at the University of Colorado School of Medicine, and an Adjunct Professor in the Department of Health Systems Science of at the Bernard J. Tyson Kaiser Permanente School of Medicine.
Dr. Binswanger received her MD from the University of California, San Francisco, where she also completed a Primary Care Internal Medicine Residency. She completed fellowship training in the Robert Wood Johnson Clinical Scholars Program at the University of Washington and the VA.
Dr. Binswanger conducts research on how to prevent overdose and improve the delivery of clinical care to people who use substances and the health needs of people with criminal legal involvement, particularly during the transition from incarceration into the community. Her research has also assessed the safety of opioid prescribing practices such as dose variability and discontinuation.
Mark Bounthavong, PharmD, PhD, MPH is an Associate Professor of Clinical Pharmacy at Skaggs School of Pharmacy & Pharmaceutical Sciences, University of California at San Diego and the National Clinical Program Manager at the U.S. Department of Veterans Affairs (VA) Pharmacy Benefits Management. He is also a health economist at the VA Health Economics Resource Center.
He received his PharmD from the College of Pharmacy, Western University of Health Sciences and then completed his PGY-1 Pharmacy Practice Residency at the VA Loma Linda Medical Center. He went on to complete a two-year fellowship in Outcomes Research at Western University, received his Master of Public Health from the Rollins School of Public Health at Emory University, and his PhD in pharmaceutical outcomes research and policy from the Comparative Health Outcomes, Policy, and Economics (CHOICE) Institute at the University of Washington.
Mark’s research interests include pharmacoeconomics, outcomes research, health economics, process and program evaluations, econometric methods, and evidence synthesis using Bayesian methods. He has performed value assessments of therapeutics for schizophrenia, cardiology, and infectious diseases. More recently, he has focused his research on substance use disorder and the behavioral strategies used to mitigate this issue, particularly academic detailing, which is an outreach delivered by clinicians to augment and align other clinician’s prescribing behavior with evidence-based practice. He currently is working to understand the financial risks associated with substance use disorders.
Deborah S. Finnell, PhD, RN, CARN-AP, FAAN is Professor Emerita at Johns Hopkins University School of Nursing, a Fellow in the American Academy of Nursing (FAAN) and is board certified at the advanced practice level in addictions nursing (CANR-AP). Throughout her career, Dr. Finnell held teaching and leadership roles in academia as well as clinical and administrative roles in private, public, and federal healthcare systems focusing on psychiatric mental health and substance use-related care. Dr. Finnell translated the neurobiological science related to mental and substance use disorders in her clinical practice, teaching, research, and policy/advocacy work. She served as Chairperson of the Addictions Nursing Certification Board (2002-2007) and President of the International Nurses Society on Addictions (2010-2012). She served on the Board of Directors for AMERSA (2017-2017) with service as President-Elect (2019-2022) and currently serves as President.
Dr. Finnell has been the recipient of several federal grants supporting the advancement of nurses’ substance use-related knowledge and competence. Dr. Finnell led the development of substance use-related competencies for nurses, including graduate-level and advanced-practice nurses, published in SAj, and served as co-editor for the American Nurses Association/International Nurses Society on Addictions 2013 edition of the Scope and Standards of Addictions Nursing. Dr. Finnell has over 100 peer-reviewed publications (h-index 23; i-10-index 38) and book chapters, 30 of which relate specifically to alcohol and or other drugs.
She obtained her baccalaureate degree in nursing from Roberts Wesleyan College, masters degree in psychiatric-mental health nursing and post-master’s in psychiatric-mental health nursing from the University at Buffalo, Buffalo, NY where she also earned her doctoral degree in nursing. She completed a post-doctoral fellowship at the VA of Western New York (2005-2007). Dr. Finnell received the Excellence in Research Award (2010), Excellence in Education Award (2009), and Distinguished Faculty Mentor Awards (2007, 2008) from the University at Buffalo School of Nursing.
She lives in East Amherst, New York with her husband Timothy where they share a passion for landscaping and gardening. They are invested in the implementation of a K-12 curriculum based on the brain, body, and environment building blocks to foster integrative critical thinking.
Elizabeth M. Oliva, PhD received her PhD in Developmental Psychopathology and Clinical Science from the University of Minnesota where her graduate work examining the etiology of substance use from adolescence to early adulthood was funded by a National Science Foundation Graduate Fellowship.
She completed her pre-doctoral clinical psychology internship at UCSD/VA San Diego. Dr. Oliva is a Senior Evaluator for the VA Program Evaluation and Resource Center (PERC; one of three VA Office of Mental Health and Suicide Prevention evaluation centers) and an Investigator at the VA Center for Innovation to Implementation (Ci2i) at the VA Palo Alto Health Care System.
She is the VA National Opioid Overdose Education and Naloxone Distribution (OEND) Coordinator and also conducts research on VA OEND implementation and post-overdose care. In her role as VA National OEND Coordinator, Dr. Oliva works with interdisciplinary teams—e.g., MDs, PharmDs, RNs, LCSWs, Psychologists—to create national VA OEND resources for patient and provider training.
She is also supporting national implementation of other harm reduction interventions in VA, including Syringe Services Programs (SSPs) and fentanyl test strips. Dr. Oliva also helped develop and implement the VA Stratification Tool for Opioid Risk Mitigation (STORM).
Marianne Pugatch, Ph.D., MSW, is an Assistant Professor of Psychiatry and Behavioral Sciences at Ann & Robert H. Lurie Children’s Hospital of Chicago/Northwestern University Feinberg School of Medicine. Dr. Pugatch develops digital health interventions to prevent risky alcohol use in underserved youth. She also researches the optimal implementation of substance use prevention and treatment practices into healthcare delivery systems. Her research includes collaborating with youth and caregivers and seeks to interrupt the high-risk addiction trajectory in adolescence, reduce opioid overdose risk and mitigate health disparities.
Dr. Pugatch received her Ph.D. from the Heller School for Social Policy and Management in social science and policy research as an NIAAA trainee. While completing her doctorate, she trained as an advanced interprofessional addiction fellow at the Boston VA Healthcare System and, worked at the Center for Healthcare Organization and Implementation Research, VA Boston, examining how to improve the quality of healthcare for Veterans. Before research training, Dr. Pugatch was the clinical director of social work at the Adolescent Substance Use and Addiction Program, Boston Children’s Hospital, where she co-developed and pilot-tested one of the first opioid use disorder group programs for youth and caregivers. As a teaching associate at Harvard Medical School, she supervised, mentored, and trained staff, fellows, and students in addiction medicine. In her free time, she enjoys hiking, watching movies, and being with her family and cat, Charlotte.
Elizabeth Siantz, PhD, MSW is an Assistant Professor in the College of Social Work at the University of Utah. Her research focuses on the promotion of health equity for persons with mental illness and substance use disorders. She is a mixed methods implementation scientist who studies the development and implementation of integrated primary care and behavioral health services and peer support specialists across a range of clinical and cultural settings.
Dr. Siantz received her MSW from Columbia University and then completed her PhD in social welfare at the University of Southern California. She completed her postdoctoral training at the University of California San Diego Herbert Wertheim School of Public Health.
Jessica J Wyse, PhD, MPP is Assistant Professor in the OHSU-PSU School of Public Health, Core Investigator at the VA Portland Health Care System’s (VAPORHCS) Health Services Research & Development (HSR&D) Center to Improve Veteran Involvement in Care (CIVIC) and Associate Director of VA Portland’s HSR&D Advanced Fellowship Program.
Dr. Wyse received a doctorate in Sociology and Public Policy from the University of Michigan, Ann Arbor, where she also completed a post-doctoral fellowship at the Institute for Social Research. She received further training in health services research as an OAA postdoctoral fellow at the VA Portland Health Care System.
Dr. Wyse’s research seeks to understand how to enhance access to, and delivery of, medications for opioid use disorder (MOUD) and other evidence-based treatments for substance use disorders. She often uses qualitative research methods to draw out patient experiences and perspectives with the goal of informing and improving upon programs, policies and care delivery.
Taneisha Scheuermann, PhD is an Associate Professor in Population Health at the University of Kansas Medical Center on the Kansas City campus. She is a counseling psychologist, and her research focuses on smoking cessation. Dr. Scheuermann has a strong emphasis on health disparities, including racial/ethnic and socioeconomic disparities related to tobacco use and associated health outcomes. Her research to-date has focused on nondaily and daily smokers, racial and ethnic minorities, hospitalized patients, and pregnant and postpartum populations. Research interest areas include dissemination and implementation science, mHealth, clinical trials, and survey research. She enjoys reading, travel, and walking her dog.